Alterations in Cisplatin Pharmacokinetics and Its Acute/Sub-chronic Kidney Injury over Multiple Cycles of Cisplatin Treatment in Rats-Reference-Cited by-同舟云学术

Alterations in Cisplatin Pharmacokinetics and Its Acute/Sub-chronic Kidney Injury over Multiple Cycles of Cisplatin Treatment in Rats

Published:2017 Issue:11 Volume:40 Page:1948-1955
ISSN:0918-6158
Container-title:Biological & Pharmaceutical Bulletin
language:en
Short-container-title:Biol. Pharm. Bull.

Author:

Okada Akira¹,Fukushima Keizo¹,Fujita Mai¹,Nakanishi Mana¹,Hamori Mami²,Nishimura Asako²,Shibata Nobuhito²,Sugioka Nobuyuki¹

Affiliation:

1. Department of Clinical Pharmacokinetics, Faculty of Pharmaceutical Sciences, Kobe Gakuin University

2. Department of Biopharmaceutics, Faculty of Pharmaceutical Science, Doshisha Women’s College of Liberal Arts

Publisher

Pharmaceutical Society of Japan

Subject

Pharmaceutical Science,Pharmacology,General Medicine

Link

https://www.jstage.jst.go.jp/article/bpb/40/11/40_b17-00499/_pdf

Reference31 articles.

1. 1) Faig J, Haughton M, Taylor RC, D’Agostino RB Jr, Whelen MJ, Porosnicu Rodriguez KA, Bonomi M, Murea M, Porosnicu M. Retrospective analysis of cisplatin nephrotoxicity in patients with head and neck cancer receiving outpatient treatment with concurrent high-dose cisplatin and radiotherapy. Am. J. Clin. Oncol., 2016, 1 (2016).

2. 2) Latcha S, Jaimes EA, Patil S, Glezerman IG, Mehta S, Flombaum CD. Long-term renal outcomes after cisplatin treatment. Clin. J. Am. Soc. Nephrol., 11, 1173–1179 (2016).

3. 3) Cole WC, Wolf W. Preparation and metabolism of a cisplatin/serum protein complex. Chem. Biol. Interact., 30, 223–235 (1980).

4. 4) Hanada K, Ninomiya K, Ogata H. Pharmacokinetics and toxicodynamics of cisplatin and its metabolites in rats: relationship between renal handling and nephrotoxicity of cisplatin. J. Pharm. Pharmacol., 52, 1345–1353 (2000).

5. 5) Filipski KK, Mathijssen RH, Mikkelsen TS, Schinkel AH, Sparreboom A. Contribution of organic cation transporter 2 (OCT2) to cisplatin-induced nephrotoxicity. Clin. Pharmacol. Ther., 86, 396–402 (2009).

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Isoliquiritigenin pretreatment regulates ER stress and attenuates cisplatin‐induced nephrotoxicity in male Wistar rats;Journal of Biochemical and Molecular Toxicology;2023-08-10

2. Nephroprotective effects of gallic acid and hesperidin in aluminum chloride-induced toxicity in rats;Phytomedicine Plus;2022-11

3. Comparison of cisplatin-induced nephrotoxicity between single-dose and split-dose administration to rats;Biomedicine & Pharmacotherapy;2022-03

4. Cisplatin Mouse Models: Treatment, Toxicity and Translatability;Biomedicines;2021-10-07

5. Risk and impact of delayed renal impairment in patients with locally advanced head and neck squamous cell carcinoma receiving chemoradiotherapy with cisplatin;Supportive Care in Cancer;2020-06-10